Glaxosmithkline Pharmaceuticals is currently trading at Rs 2929.60, up by 9.40 points or 0.32% from its previous closing of Rs. 2920.20 on the BSE.
The scrip opened at Rs. 2913.00 and has touched a high and low of Rs. 2935.00 and Rs. 2905.00 respectively. So far 957 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 3850.00 on 31-Mar-2016 and a 52 week low of Rs. 2752.05 on 30-Sep-2016.
Last one week high and low of the scrip stood at Rs. 2,988.00 and Rs 2905.00 respectively. The current market cap of the company is Rs. 24648.58 crore.
The promoters holding in the company stood at 75.00%, while Institutions and Non-Institutions held 11.99% and 13.01% respectively.
GlaxoSmithKline Pharmaceuticals reported 3.45% rise in its net profit at Rs 98.85 crore for the quarter ended September 30, 2016 as compared to Rs 95.55 crore for the same quarter in the previous year. Total income of the company increased by 9.12% at Rs 817.20 crore for the quarter under review as compared Rs 748.87 crore for the corresponding quarter previous year.
GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |